LEADER 01437nam  2200385Ia 450 
001 9910700778203321
005 20110708170351.0
035   $a(CKB)5470000002411222
035   $a(OCoLC)740082639
035   $a(EXLCZ)995470000002411222
100   $a20110708d1994      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aIssues associated with use of strontium-89 and other beta emitting radiopharmaceuticals$b[electronic resource]
210  1$aWashington, DC :$cU.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards,$d[1994]
215   $a1 online resource
225 1 $aNRC information notice ;$v94-70
300   $aTitle from HTML title screen (viewed on July 8, 2011).
300   $a"September 29, 1994."
606   $aStrontium$xPhysiological effect
606   $aRadiopharmaceuticals
606   $aBeta rays$xPhysiological effect
615  0$aStrontium$xPhysiological effect.
615  0$aRadiopharmaceuticals.
615  0$aBeta rays$xPhysiological effect.
712 02$aU.S. Nuclear Regulatory Commission.$bOffice of Nuclear Material Safety and Safeguards.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910700778203321
996   $aIssues associated with use of strontium-89 and other beta emitting radiopharmaceuticals$93217412
997   $aUNINA